Mortality and healthcare assessment among patients with chronic disease over 2 years of COVID-19: a population-based study in a large hard-hit Italian region
Authors:
Open Access
Abstract
Objectives We aimed to provide a region-wide comprehensive account of the indirect effects of COVID-19 on patients with chronic disease, in terms of non-COVID-19 mortality, and access to both inpatient and outpatient health services over a 2-year pandemic period. Design Population-based retrospective study. Setting Adult patients, affected by at least 1 of 32 prevalent chronic conditions, residing in the Emilia-Romagna Region in Italy, during the years 2020 (N=1 791 189, 47.7% of the overall adult regional population) and 2021 (N=1 801 071, 47.8%). Results Overall, non-COVID-19 mortality among patients with chronic disease during the pandemic (2.7%) did not differ substantially from the expected mortality (2.5%), based on a 3 years prepandemic period (2017–2019) and adjusting for the demographic and clinical characteristics of the population under study. Indeed, while the first pandemic wave was characterised by a significant non-COVID-19 excess mortality (March: +35%), the subsequent phases did not show such disruptive variations in non-COVID-19 deaths, which remained around or even below the excess mortality threshold. End-of-life care of patients with chronic disease, especially for non-COVID-19 cases, significantly shifted from hospitalisations (−19%), to homecare (ADI: +7%; w/o ADI: +9%). Overall, healthcare of patients without COVID-19 chronic disease decreased, with similar negative trends in hospitalisations (−15.5%), major procedures (−19.6%) and ER accesses (−23.7%). Homecare was the least affected by the pandemic, with an overall reduction of −9.8%. COVID-19 outbreak also impacted on different types of outpatient care. Rehabilitation therapies, specialist visits, diagnostic and lab tests were considerably reduced during the first pandemic wave and consequent lockdown, with access rates of patients without COVID-19 chronic disease below −60%. Conclusions This work thoroughly describes how a large and well-defined population of patients without COVID-19 chronic disease has been affected by the changes and reorganisation in the healthcare system during 2 years of the pandemic, highlighting health priorities and challenges in chronic disease management under conditions of limited resources.Keywords
This publication has 50 references indexed in Scilit:
- Impact of COVID-19 on routine care for chronic diseases: A global survey of views from healthcare professionalsDiabetes & Metabolic Syndrome: Clinical Research & Reviews, 2020
- The Invisible Epidemic: Neglected Chronic Disease Management During COVID-19Journal of General Internal Medicine, 2020
- Reduced Rate of Hospital Admissions for ACS during Covid-19 Outbreak in Northern ItalyNew England Journal of Medicine, 2020
- Integration of palliative care into COVID-19 pandemic planningBMJ Supportive & Palliative Care, 2020
- The potential long-term impact of the COVID-19 outbreak on patients with non-communicable diseases in Europe: consequences for healthy ageingAging Clinical and Experimental Research, 2020
- Providing quality end-of-life care to older people in the era of COVID-19: perspectives from five countriesInternational Psychogeriatrics, 2020
- Interrupted time series regression for the evaluation of public health interventions: a tutorialInternational Journal of Epidemiology, 2016
- Time series regression studies in environmental epidemiologyInternational Journal of Epidemiology, 2013
- Segmented regression analysis of interrupted time series studies in medication use researchJournal of Clinical Pharmacy and Therapeutics, 2002
- On a measure of lack of fit in time series modelsBiometrika, 1978